P-glycoprotein-activity measurements in multidrug resistant cell lines: Single-cell versus single-well population fluorescence methods

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Pasquier, Jennifer ^a,b,c   Rioult, Damien ^a   Abu Kaoud, Nadine ^c   Marie, Sabine ^a   Rafii, Arash ^b,c   Guerrouahen, Bella S ^b,c   Le Foll, Frank ^a  

^a Université du Havre   (France)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN ACETOXYMETHYL ESTER; FLUORESCENT DYE; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL; CALCEIN AM; FLUORESCEIN DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL COUNT; CELL FLUORESCENCE CONCENTRATION; CELL LINE; CELL POPULATION; CELL VOLUME; CONTROLLED STUDY; EFFUSION; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MEASUREMENT REPEATABILITY; MICROPLATE READER; MULTIDRUG RESISTANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE CELL FLUORESCENCE; DRUG RESISTANCE; MCF 7 CELL LINE; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUORESCEINS; FLUORESCENCE; HUMANS; MCF-7 CELLS; P-GLYCOPROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 84890021295     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/676845     Document Type: Article

References (22)

1. Pluen A., Boucher Y., Ramanujan S., McKee T. D., Gohongi T., Di Tomaso E., Brown E. B., Izumi Y., Campbell R. B., Berk D. A., Jain R. K., Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial versus subcutaneous tumors. Proceedings of the National Academy of Sciences of the United States of America 2001 98 8 4628 4633 2-s2.0-0035836641 10.1073/pnas.081626898 (Pubitemid 32295027)
2. Druker B. J., Sawyers C. L., Kantarjian H., Resta D. J., Reese S. F., Ford J. M., Capdeville R., Talpaz M., Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. The New England Journal of Medicine 2001 344 14 1038 1042 2-s2.0-0035810142 10.1056/ NEJM200104053441402 (Pubitemid 32267973)
3. Biedler J. L., Riehm H., Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Research 1970 30 4 1174 1184 2-s2.0-0014767029
4. Endicott J. A., Ling V., The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry 1989 58 137 171 2-s2.0-0024329881 10.1146/annurev.bi.58.070189.001033 (Pubitemid 19172967)
5. Bosch I., Croop J., P-glycoprotein multidrug resistance and cancer. Biochimica et Biophysica Acta 1996 1288 2 F37 F54 2-s2.0-0030577119 10.1016/0304-419X(96)00022-4 (Pubitemid 26335491)
6. Ambudkar S. V., Dey S., Hrycyna C. A., Ramachandra M., Pastan I., Gottesman M. M., Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Review of Pharmacology and Toxicology 1999 39 361 398 2-s2.0-0032900953 10.1146/annurev.pharmtox.39.1.361 (Pubitemid 29222564)
7. Ambudkar S. V., Kimchi-Sarfaty C., Sauna Z. E., Gottesman M. M., P-glycoprotein: from genomics to mechanism. Oncogene 2003 22 47 7468 7485 2-s2.0-0344825356 10.1038/sj.onc.1206948 (Pubitemid 37487170)
8. Schinkel A. H., The physiological function of drug-transporting P-glycoproteins. Seminars in Cancer Biology 1997 8 3 161 170 2-s2.0-0031158805 10.1006/scbi.1997.0068 (Pubitemid 28041013)
9. Holland I. B., A. Blight M., ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. Journal of Molecular Biology 1999 293 2 381 399 2-s2.0-0032698874 10.1006/jmbi.1999.2993 (Pubitemid 29516178)
10. Turk D., Szakacs G., Relevance of multidrug resistance in the age of targeted therapy. Current opinion in Drug Discovery & Development 2009 12 246 252
11. Trock B. J., Leonessa F., Clarke R., Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. Journal of the National Cancer Institute 1997 89 13 917 931 2-s2.0-0030920342 10.1093/jnci/89.13.917 (Pubitemid 27282064)
12. Faneyte I. F., Kristel P. M., van de Vijver M. J., Determining MDR1/P-glycoprotein expression in breast cancer. The International Journal of Cancer 2001 93 114 122 (Pubitemid 32539510)
13. Beck W. T., Grogan T. M., Willman C. L., Cordon-Cardo C., Parham D. M., Kuttesch J. F., Andreeff M., Bates S. E., Berard C. W., Boyett J. M., Brophy N. A., Broxterman H. J., Chan H. S. L., Dalton W. S., Dietel M., Fojo A. T., Gascoyne R. D., Head D., Houghton P. J., Srivastava D. K., Lehnert M., Leith C. P., Paietta E., Pavelic Z. P., Rimsza L., Roninson I. B., Sikic B. I., Twentyman P. R., Warnke R., Weinstein R., Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Research 1996 56 13 3010 3020 2-s2.0-8944261743 (Pubitemid 26199746)
14. Broxterman H. J., Sonneveld P., Feller N., Ossenkoppele G. J., Währer D. C. R., Eekman C. A., Schoester M., Lankelma J., Pinedo H. M., Löwenberg B., Schuurhuis G. J., Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood 1996 87 11 4809 4816 2-s2.0-9344264652 (Pubitemid 26162383)
15. Meesungnoen J., Jay-Gerin J.-P., Mankhetkorn S., Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines. Canadian Journal of Physiology and Pharmacology 2002 80 11 1054 1063 2-s2.0-0036902448 10.1139/y02-132 (Pubitemid 36002662)
16. Pasquier J., Galas L., Boulangé-Lecomte C., Rioult D., Bultelle F., Magal P., Webb G., Le Foll F., Different modalities of intercellular membrane exchanges mediate cell-to-cell P-glycoprotein transfers in MCF-7 breast cancer cells. The Journal of Biological Chemistry 2012 287 10 7374 7387 2-s2.0-84857746017 10.1074/jbc.M111.312157
17. Legrand O., Simonin G., Perrot J. Y., Zittoun R., Marie J. P., Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood 1998 91 12 4480 4488 2-s2.0-0031864247 (Pubitemid 28270294)
18. Homolya L., Hollo Z., Germann U. A., Pastan I., Gottesman M. M., Sarkadi B., Fluorescent cellular indicators are extruded by the multidrug resistance protein. The Journal of Biological Chemistry 1993 268 29 21493 21496 2-s2.0-0027432409 (Pubitemid 23320634)
19. Marin M., Legros H., Poret A., Leboulenger F., Le Foll F., Cell responses to xenobiotics: comparison of MCF7 multi-drug- and mussel blood cell multi-xenobiotic-defense mechanisms. Marine Environmental Research 2004 58 2-5 209 213 2-s2.0-2942546252 10.1016/j.marenvres.2004.03.016 (Pubitemid 38738883)
20. Pasquier J., Magal P., Boulangé-Lecomte C., Webb G., Le Foll F., Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model. Biology Direct 2011 6 article 5 2-s2.0-79251540574 10.1186/1745-6150-6-5
21. Altman D. G., Bland J. M., Comparison of methods of measuring blood pressure. Journal of Epidemiology and Community Health 1986 40 3 274 277 2-s2.0-0022780097
22. Maulard C., Marie J.-P., Delanian S., Housset M., Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer. European Journal of Cancer A 1993 29 3 480 2-s2.0-0027392322 10.1016/0959-8049(93)90413 Rfaut (Pubitemid 23025766)